ea0022p241 | Clinical case reports and clinical practice | ECE2010
Laszlo Ferenc A
, Gervain Mihaly
, Voros Erika
, Molnar Andor H
, Laszlo Ferenc
Twelve years following hemicolectomy for colon adenocarcinoma, a 75-year-old patient with prostate cancer was treated for 4 weeks with the antiandrogen nilutamide and then with the long-acting GnRH agonist buserelin. The serum testosterone and prostate-specific antigen (PSA) levels had decreased dramatically after 3 months of treatment. After 2 years of buserelin administration, the hormonal state was examined. Serum estradiol, testosterone, DHEA, DHEAS, FSH and LH levels prov...